Evidence map›Paper›PMID 28944139›Full record

ArticleIntractable & rare diseases research2017

A novel

Toshiyuki Seto, Takashi Hamazaki, Satsuki Nishigaki, Satoshi Kudo, Haruo Shintaku, Yumiko Ondo, Keiko Shimojima, Toshiyuki Yamamoto

Open access · diamondAbstract read
In one paragraph

Article in Intractable & rare diseases research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. The neurodevelopmental spectrum of CASK-related disorder.Journal of neurodevelopmental disorders · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Case Report: Identification of a novelFrontiers in genetics · 2022
    Article
  11. Case report: A novelFrontiers in genetics · 2022
    Article
  12. Alterations of presynaptic proteins in autism spectrum disorder.Frontiers in molecular neuroscience · 2022
    Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Toshiyuki SetoDepartment of Pediatrics, Osaka City University, Osaka, Japan.
Takashi HamazakiDepartment of Pediatrics, Osaka City University, Osaka, Japan.
Satsuki NishigakiDepartment of Pediatrics, Osaka City University, Osaka, Japan.
Satoshi KudoDepartment of Pediatrics, Osaka City University, Osaka, Japan.
Haruo ShintakuDepartment of Pediatrics, Osaka City University, Osaka, Japan.
Yumiko OndoInstitute of Medical Genetics, Tokyo Women's Medical University, Tokyo, Japan.
Keiko ShimojimaInstitute of Medical Genetics, Tokyo Women's Medical University, Tokyo, Japan.
Toshiyuki YamamotoInstitute of Medical Genetics, Tokyo Women's Medical University, Tokyo, Japan.
Osaka City University · JPTokyo Women's Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The calcium/calmodulin-dependent serine protein kinase gene (

Indexed as

Autismmanifesting carriernext generation sequencingobligate carrierX-chromosome inactivation

Identifiers

PMID28944139
PMCPMC5608927
OpenAlexW2741753564

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.